Mendelspod Podcast

Mendelspod was founded in 2011 by Theral Timpson and Ayanna Monteverdi to advance life science research, connecting people and ideas. Influenced by the thinking tools developed by Eli Goldgratt, the founders bring a unique approach to media in the life sciences. With help from our advisors around the industry, Mendelspod goes beyond quick sound bites to create a space for probing conversations and deep insight into the topics and trends which shape the industry's future and therefore our future as a species.

https://mendelspod.com/

Eine durchschnittliche Folge dieses Podcasts dauert 29m. Bisher sind 448 Folge(n) erschienen. Alle 5 Tage erscheint eine Folge dieses Podcasts
subscribe
share



 

June 2019 Review with Nathan and Laura: Gene Patents, Grail, Dr. Lynch


Nathan and Laura join Theral for our final review show before the summer break. Have you already headed out on vacation? Take us along and stay current with the top stories in genomics. This month it's gene patents (yes, Congress is really reviving that debate), another gene therapy with another astronomical price tag, and remembering Dr. Henry Lynch of Lynch Syndrome fame.


share





 2019-07-01  n/a
 
 

Should Genomic Screening Be Standard of Care? with Adam Buchanan, Geisinger


Those of us watching every shift in the level of adoption of genomic medicine have our eyes closely glued to Geisinger Health System in Pennsylvania. Adam Buchanan is the Co-Director of Geisinger’s MyCode Genomic Screening and Counseling program, and today we talk to him about the rationale of making genomic screening part of routine medical care.


share





 2019-06-25  n/a
 
 

Should a Genomic Screen Be Standard of Care? with Adam Buchanan, Geisinger


Those of us watching every shift in the level of adoption of genomic medicine have our eyes closely glued to Geisinger Health System in Pennsylvania. Adam Buchanan is the Co-Director of Geisinger’s MyCode Genomic Screening and Counseling program, and today we talk to him about the rationale of making genomic screening part of routine medical care.


share





 2019-06-25  n/a
 
 

May 2019 Review with Nathan and Laura: Gene Therapies, DTC Shifts, Gender and Sports


Our two reigning champions are back for a month packed with news. It’s Nathan Pearson of Root and Laura Hercher of Sarah Laurence College and Host of The Beagle Has Landed Podcast daring to go where no genomics commentators have gone before.


share





 2019-05-31  n/a
 
 

Toward the Human Pan Genome with Adam Phillippy, NHGRI


Storylines repeat each other in genomic science every decade or so. The human genome is complete. No. Now it's complete. Or, in the 90's, it was first announced that the first chromosome was sequenced. We have the same story for you today-- supposedly breaking news from a paper that has not even been published yet: the first “complete” assembly of a human chromosome, end to end, telomere to telomere. So what’s going on?


share





 2019-05-23  n/a
 
 

Please! No Horoscopes on the Science Page: Laura Hercher Talks DTC Genetic Testing


"DTC is now too big of an arena to put everything in the same bucket.” This was a line from Laura Hercher, one of our monthly commentators a couple shows back. The line represents a certain zeitgeist today, making its way around Twitter, so we thought we’d have Laura back to the program and ask her to come up with some more buckets. It turns out it’s not that easy.  Direct-to-consumer genetic testing is a dynamic and complex space in 2019, a mishmash that quite defies easy categorization.


share





 2019-05-16  n/a
 
 

Laura Hercher on the DTC Genetic Testing Landscape


"DTC is now too big of an arena to put everything in the same bucket.” This was a line from Laura Hercher, one of our monthly commentators a couple shows back. The statement made its way around Twitter, so we thought we’d have Laura back to the program and ask her to come up with some more buckets. It turns out it’s not that easy.  Direct-to-consumer genetic testing is a dynamic and complex space in 2019, a mishmash that quite defies easy categorization.


share





 2019-05-16  n/a
 
 

No Horoscopes on the Science Page: Laura Hercher Talks DTC Genetic Testing


"DTC is now too big of an arena to put everything in the same bucket.” This was a line from Laura Hercher, one of our monthly commentators a couple shows back. The line represents a certain zeitgeist today, making its way around Twitter, so we thought we’d have Laura back to the program and ask her to come up with some more buckets. It turns out it’s not that easy.  Direct-to-consumer genetic testing is a dynamic and complex space in 2019, a mishmash that quite defies easy categorization.


share





 2019-05-16  n/a
 
 

Arcadia Biosciences Jujitsus Around GMO Resistance with GoodWheat and Better Cannabis


Today we're joined by Matt Plavan, President of Arcadia Specialty Genomics. The last time we talked with someone from Arcadia Bioscience, a biotech company working on plant genomics in Davis, California, they were confronting GMO regulatory hurdles. Which was a pity. They had created these great new strains of rice and soybeans, among other crops, that were being held from market due to regulations in Southeast Asia. This at a time when world population is . . . well, you know what its doing.


share





 2019-05-09  n/a
 
 

Arcadia Biosciences Pivots to Bring Us Non-GMO, High Fiber GoodWheat and Better Cannabis


Today we're joined by Matt Plavan, President of Arcadia Specialty Genomics. The last time we talked with someone from Arcadia Bioscience, a biotech company working on plant genomics in Davis, California, they were confronting GMO regulatory hurdles. Which was a pity. They had created these great new strains of rice and soybeans, among other crops, that were being held from market due to regulations in Southeast Asia. This at a time when world population is . . . well, you know what its doing.


share





 2019-05-09  n/a